A randomized trial of rapid genetic counseling versus usual care for high-risk women with newly diagnosed breast cancer
Rachel Nusbaum(Icahn School of Medicine at Mount Sinai), Marc A. Schwartz(University of Washington), Marie Pennanen(Unknown), Rebecca S. Evangelista(Icahn School of Medicine at Mount Sinai), Sarah A. Kelleher(Icahn School of Medicine at Mount Sinai), Scott P. Kelly(Pfizer (United States)), Jessica Rowse(Icahn School of Medicine at Mount Sinai), Claudine Isaacs(Georgetown University), Heiðdís Valdimarsdóttir(Icahn School of Medicine at Mount Sinai), Beth N. Peshkin(Georgetown University), Shawna C. Willey(Georgetown University), Costanza Cocilovo(Icahn School of Medicine at Mount Sinai)
Cancer Epidemiology and Prevention Biomarkers
December 1, 2007
Cited by 0
Related Papers
Elastography of breast lesions: initial clinical results.
|Radiology|1997|934
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer
|JAMA Oncology|2020|707
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: The PROSE Study Group
|Journal of Clinical Oncology|2005|406